These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18713851)

  • 1. The INSPIRE study: influence of prior use and discontinuation of inhaled corticosteroids.
    Lanes SF; Jara M
    Am J Respir Crit Care Med; 2008 Sep; 178(5):543-4; author reply 544. PubMed ID: 18713851
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled glucocorticoids and COPD exacerbations.
    Cosio M; Baraldo S; Saetta M
    N Engl J Med; 2015 Jan; 372(1):92. PubMed ID: 25551536
    [No Abstract]   [Full Text] [Related]  

  • 3. Stepping down therapy in COPD.
    Reilly JJ
    N Engl J Med; 2014 Oct; 371(14):1340-1. PubMed ID: 25196116
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhaled glucocorticoids and COPD exacerbations.
    Brightling CE; Pavord ID; Bafadhel M
    N Engl J Med; 2015 Jan; 372(1):93. PubMed ID: 25551538
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhaled glucocorticoids and COPD exacerbations.
    Singanayagam A; Johnston SL; Mallia P
    N Engl J Med; 2015 Jan; 372(1):92-3. PubMed ID: 25551537
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhaled glucocorticoids and COPD exacerbations.
    Magnussen H; Tetzlaff K; Calverley PM
    N Engl J Med; 2015 Jan; 372(1):93-4. PubMed ID: 25551535
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP journal club. For preventing exacerbations of COPD, withdrawal of inhaled glucocorticoids was noninferior to continuation.
    Stanbrook MB
    Ann Intern Med; 2015 Mar; 162(6):JC5. PubMed ID: 25775348
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuing inhaled steroids might not be safe in severe COPD cases.
    Laniado-Laborín R
    Evid Based Med; 2015 Apr; 20(2):57. PubMed ID: 25595701
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.
    Maltais F; Mahler DA; Pepin V; Nadreau E; Crater GD; Morris AN; Emmett AH; Ferro TJ
    Eur Respir J; 2013 Aug; 42(2):539-41. PubMed ID: 23904549
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
    [No Abstract]   [Full Text] [Related]  

  • 11. Outpatient management of severe COPD.
    Singh S; Loke YK; Furberg CD
    N Engl J Med; 2010 Jul; 363(5):493-4; author reply 494-5. PubMed ID: 20666630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Triple therapy in chronic obstructive pulmonary disease].
    Baloira A
    Arch Bronconeumol; 2010; 46 Suppl 8():25-30. PubMed ID: 21334553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evidence of pharmacotherapy in COPD--key findings from recently-conducted randomized clinical studies].
    Shimizu K; Nishimura M
    Nihon Rinsho; 2011 Oct; 69(10):1815-20. PubMed ID: 22073579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs.
    Suissa S
    Am J Respir Crit Care Med; 2008 Aug; 178(4):322-3. PubMed ID: 18676961
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhalation of beta-2 agonists or corticosteroids as single drugs in comparison with combination therapy of patients with COPD].
    Steurer-Stey C
    Praxis (Bern 1994); 2003 Jul; 92(31-32):1324-5. PubMed ID: 12934343
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-acting inhaled bronchodilators for COPD--lack of logic continues.
    Jones D
    N Z Med J; 2005 Sep; 118(1222):U1669. PubMed ID: 16222360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].
    Pedersen ST
    Ugeskr Laeger; 2005 Jun; 167(23):2504-6. PubMed ID: 16008004
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD guidelines: the important thing is not to stop questioning.
    Fabbri LM; Boschetto P; Mapp CE; ;
    Am J Respir Crit Care Med; 2007 Sep; 176(6):527-8. PubMed ID: 17823358
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.